ASCO年会倒计时:港股抗癌概念股狂飙,康方生物、堃博医疗领涨创新药赛道

金融界
Yesterday

当地时间5月30日,全球肿瘤学界的年度盛会——美国临床肿瘤学会(ASCO)年会将在芝加哥拉开帷幕。这场被誉为“肿瘤学界奥斯卡”的学术盛宴,不仅是全球顶尖药企展示最新研发成果的舞台,更成为资本市场提前押注抗癌概念股的“风向标”。尽管距离年会正式开幕尚有月余,港股市场的抗癌概念股已提前进入“狂飙模式”,康方生物、堃博医疗等企业股价接连创下历史新高,而荣昌生物、信达生物、亚盛医药等一众创新药企亦紧随其后...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10